{"ticker": {"uuid": "9851ef2c-119b-41be-8aac-a879e2ae400f", "symbol": "ADXN", "name": "Addex Therapeutics Ltd", "exchange": "EBS", "country": "CH", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigJBVV95cUxPaXVuNUZRZTBvbktqMlc1N1d0Rk1kZnhKZWJ3MHVDZjhNSHo3Q2NiZzI1OUZ4R3BWLUQ3Q2hXbjVFblBiS1ktZGdwcElBVWNMNGZqTTBvR1R4STNwX0tnTV8wMGlVVjZRZjN4QllEYjYyU1hnQW8zS19NZVVqLWNRMTNaeC1CZ3dnUGdmMkFBSGZQQWZWLWlKTDEya0JiR09KblJyek5yX0tiYWtUcmNjVTVPQ3l2SHoxWEd5aE9aNF8zVERVdmNld01TS1ZxbVNiWmJJRW5yTkpKRWxpTG5tV2cxc0NwY1ZqODRGMkdyN1JJREs0aWZIbXlINHFZckZpbml4RnVQOHpqUQ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-06-22T05:00:00+00:00", "published_display": "22 Jun 2026 05:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE1lVExIZV9za0NkUF9wUnZIQ3VxdU9CZXVKT2xMeUt5c0pZcnc4Z0tpQ0I2b3dLcG1FYUtrb2l4SllrOUVGaXgzQkVIbGgyWXZkZ2M0bUwyVGNhMjBsX19fM21NSnpGelFRTjNIcVhyWQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Institutional Confidence", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE1GeE9ZejRhRTVNY1ZyLW1RVTk0X0M1T1c4VWNjeXFPQ0FEWDVOQkNuRHJxQWJIcmpYNHZZaTVfRVJvNWN0UlJsRG8yTERieGI5d1pZWnZCbUxpQWZkRk5qSTkzMG5EaXRzUkJFWUpVX2w?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE9EV1ZfcGx5X1NZLWY1dlNreG9lcUFlOVI3R0tLWFFJMTdBQWdZOTBXcG5JeERXbGNXbVJhdG83YVJpZ0NTM0NtenVURDhyTldjM2lMaGJOYjUzaGVSOGJPakEtX3JzdjlDS1YzbEF2Wkk?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Valuation: PE, PB & Fair Value Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE5sbjgtc3VmaTVXT2E0LXhZczJKbVdSRnBSNG9pUEg3LUExQTFrcXc4LTRFZE9oTk16QUMtV1BjV1N1NTJQNjk4dVZab3BnNlB2V3VSMG9iTU83bmNncEhfeTJ3d29HbWZUWUl6ckVkbWFhZzZ2QjFGdTJ0MA?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Financial Health: Profitability & Balance Sheet Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE9UbU9ObTV0QkdWMzJBUmFTS1FsTll2eUpadDlFeTUtY0lJajgzMWU2c2I1emFxdXZVZnBmbTZsVUNsdE5hZ1lPUW9tNUtMaGFTX2t4OWY2MU8xRk51OERkSXpEV1lVWkwwOWVWUk5rZGh6SVY0eEg0M3R3?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE9fcVRYcHk5Y0NIaGRseVJ5amNzM05Jb0JSV3ZLZmRkdEpiVHBWWU1HWDNpZGxZUG5oZFdKdzZLczd5bGpTbXZERUJub3djUmdxZC1SbU5lU0V1TzdvZjc3bnFxdTc0azZQT19KUkJtTGYzSmIwOTN3?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE16OUw0a0toY29KRlJoem5rZ25kQUVRNGllU2lEY05UOWxaNWtiaU9fMDlGbEtuVnZDbzRjZXdhaS1KQ3JHR3hUWGo0YTE4RFVTakpBZ2ZvajRFbkxUQjRKbEs5TmlQa0dTYm5tV2JoZFFTcHZsRzZxOQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T01:05:28+00:00", "published_display": "18 Jun 2026 01:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE1xQktHaXc2V1RvUWJGZTdSMWNsS0Vtalh2YURVXzZDR09BY1YyWlNrb1dwWWpoZjhtbXc4dHRBVno4VkQ0UkNyV09WbGx0b2ttLWZqT2oxMUJpSVdWbTdEUzVMYWtVeGlmZjJmVjln?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T00:54:40+00:00", "published_display": "18 Jun 2026 00:54", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE1iRklOeDNXMGQ5ZFFidWdVbEdWMTNGUHJaYVhnaklYRU5HQ3drUkxkZW5xQVMxWGF5NnVYMXRNLWlGQXV1MjRHN0kxS05YbTJHRjJ3SkdpMjR6a1FOeDZjY0dhWHVRMWlKdEZPZFNqb0o?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T00:19:34+00:00", "published_display": "18 Jun 2026 00:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics (ADXN) Holds Steady \u2013 Consolidation Near Support May Signal Next Move - Short Setup Alerts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOb2NiTWE1RzB3bzN4UGc3VW0wOEU2NVB3cnlZOTZCNnFwX0Y4cDliN0s0bFhqQUpTaHQ5QU8wVFFCaTVOSkhxQ3JFVEk4OWh5NFpPeEk1ZTF1bHE5d2hCYUh2blRUWnF4bzBTMlNMS2FzME82M1JHaXdya18wTmxwUkgwUjZsUjh5YV9GcGtra2ktWEdzM1JrNVdtcFJSZ1VWM29yd3FyOGlXeTU5SVFvMlA3U1pvYlRuMWhZekVydkZodw?oc=5", "source_name": "newsline.com", "published_at": "2026-06-09T16:33:28+00:00", "published_display": "09 Jun 2026 16:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics (NASDAQ: ADXN) details 2026 AGM items and votes", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNNHYxekI0bURYR2tQaEI4NGlRZVNsNmN0bm9QVmI2cU9xaFV0a0RvZU56TF8yYmZyYWlkMF90SUdvQW5SQzNhalBCUDVHNEt2dFNhS2IxWl9XUms5TmJlQjFpMmcwRHBIYjE3clBEdFY4d1dld1A4QU9ka29QNHZQQ0RmTUhvSTFPdnFSeGlHaktFRkwzNlNEQ20wM3drRkJrZ01xaGFIX1NVd2Nqc3YxWFRkbEpiaWFUakE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Convenes Annual General Meeting 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE5sd0xjdVMxTmJJT0dvQ0VQVi1PTUQ3YVlpcmE3RE5sTmV6M3d3Nm9LeTBTTEh6VEFwQXM0bHg3S2FWQUYweElCY3VQbHlIR0RiQVNQbw?oc=5", "source_name": "Taiwan News", "published_at": "2026-06-05T05:00:00+00:00", "published_display": "05 Jun 2026 05:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics (ADXN) Slips 2.49% as Stock Tests Key Support Levels - Sector Leader Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPdUNINXlTYTV1aXd6OW5IZkJpcktFak12akQzaFBQVVF1OS1fRmFDQmo2YS1ING9mNWxwdndwNmFmYWR1cTlBbTdJNExjRUwtZHQ3Qkt5eG1wNTVMTVFldGtNbEcwZDZKTW9BZXRVVkJiYlJpZkZTbWVmSXRaVnpjVVB3ZU03MWlock9NclVvenVKV0kwcV9DUlpaWU54ZVFoZENncThJQ2hhdw?oc=5", "source_name": "newsline.com", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics (ADXN) Regains Rights to ADX71149 After Janss", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPbWlsdGEzUEVfZUlJR2xteER6VEd3cFRZN1k0T2JvNFc4ZTNFNXZPR1J1c2gtVEs4NnlsMFVVcTlMcU5qVWhKa2sySll1Skc5NFlsZTVSREpjUlRzQ3NnV1pJNl90SVdKUW9WSmhobFRjdVQ3NlE2cHA2RnZuR1dkY2RaWnNFb1h6S01TYWpfck10Zi1ReXp4V1JtVXhzN3ZKak1pMXVtOUJhSDlGcDAzdnVuZWY0REZ1anlNYVU0TkFHVUlkakl1dlFRVkN4SldqWTNDdVZqSFdGU1paZmxmdmZn?oc=5", "source_name": "GuruFocus", "published_at": "2025-04-17T07:00:00+00:00", "published_display": "17 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex and Perceptive Launch Neurosterix with $63 Million to", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgJBVV95cUxPcl93eDc1QXptQ2hpWDBOUnRaQzVDN3NGZDlBbEU5RHh5ZEdqcERQZW5qVk5vUnpIUnY2N2xkdVhoTEtkXzRRcWRGUHdKQW10LTd0U3hfRklVdC1mSXVMdGZOMTFINllqNXdGVjBUT05xVG1Ed2tLS3Y1VWZZMWNjTFBXem9JaDh2VkpfQ1RPVk1oQXk0T3ZZTDZtRnNrZDJXQTdmcF9XUDdVUG5jcnZOUjNHN0FfQUdBcW93WmpjZlVMajJ6ZnFkZkZfSjBabDRnSHJMRmdPa3NCWnNmcTJIOW95eUh1YlNjSEZOODVLZlo1VlNRVG9rTXZjNDlwRVg2dDhFZTRJUlJzekw5eDg1LThObVVPSXBqMTR4dFpzUlZ1SWVUeG5RaGgtLWQ5ZDBjQ1JVSVBZTXlyV1hZNVE?oc=5", "source_name": "GlobeNewswire", "published_at": "2024-04-03T07:00:00+00:00", "published_display": "03 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics (ADXN) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE13ellTNmhHT2xSS1p6SUVVZVlyM3NxeUlJQzNmOUpvOXVkNi15azNEcndMcVg3RU02NktROWpzSmdDLVM4TDRyellBT3hZYWhpQmJLejJ1Wk8wZw?oc=5", "source_name": "MarketBeat", "published_at": "2020-09-16T02:53:01+00:00", "published_display": "16 Sep 2020 02:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Addex Therapeutics Ltd (SIX:ADXN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9wbG9YbjVZYWp3V0NBYXN5aHBuY3piamVucUxHWVB6MldDU2hQMW5fSmo3WXRnaHN6dWtIOHdla2lBYVhPSXFTaFdBbVlhTlZkbzFfMWhFSTlKUkdvTzNLRUN3WWZLMm8?oc=5", "source_name": "TradingView", "published_at": "2018-02-05T07:37:05+00:00", "published_display": "05 Feb 2018 07:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigJBVV95cUxPaXVuNUZRZTBvbktqMlc1N1d0Rk1kZnhKZWJ3MHVDZjhNSHo3Q2NiZzI1OUZ4R3BWLUQ3Q2hXbjVFblBiS1ktZGdwcElBVWNMNGZqTTBvR1R4STNwX0tnTV8wMGlVVjZRZjN4QllEYjYyU1hnQW8zS19NZVVqLWNRMTNaeC1CZ3dnUGdmMkFBSGZQQWZWLWlKTDEya0JiR09KblJyek5yX0tiYWtUcmNjVTVPQ3l2SHoxWEd5aE9aNF8zVERVdmNld01TS1ZxbVNiWmJJRW5yTkpKRWxpTG5tV2cxc0NwY1ZqODRGMkdyN1JJREs0aWZIbXlINHFZckZpbml4RnVQOHpqUQ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-06-22T05:00:00+00:00", "published_display": "22 Jun 2026 05:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE1lVExIZV9za0NkUF9wUnZIQ3VxdU9CZXVKT2xMeUt5c0pZcnc4Z0tpQ0I2b3dLcG1FYUtrb2l4SllrOUVGaXgzQkVIbGgyWXZkZ2M0bUwyVGNhMjBsX19fM21NSnpGelFRTjNIcVhyWQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Institutional Confidence", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE1GeE9ZejRhRTVNY1ZyLW1RVTk0X0M1T1c4VWNjeXFPQ0FEWDVOQkNuRHJxQWJIcmpYNHZZaTVfRVJvNWN0UlJsRG8yTERieGI5d1pZWnZCbUxpQWZkRk5qSTkzMG5EaXRzUkJFWUpVX2w?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE9EV1ZfcGx5X1NZLWY1dlNreG9lcUFlOVI3R0tLWFFJMTdBQWdZOTBXcG5JeERXbGNXbVJhdG83YVJpZ0NTM0NtenVURDhyTldjM2lMaGJOYjUzaGVSOGJPakEtX3JzdjlDS1YzbEF2Wkk?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Valuation: PE, PB & Fair Value Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE5sbjgtc3VmaTVXT2E0LXhZczJKbVdSRnBSNG9pUEg3LUExQTFrcXc4LTRFZE9oTk16QUMtV1BjV1N1NTJQNjk4dVZab3BnNlB2V3VSMG9iTU83bmNncEhfeTJ3d29HbWZUWUl6ckVkbWFhZzZ2QjFGdTJ0MA?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Financial Health: Profitability & Balance Sheet Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE9UbU9ObTV0QkdWMzJBUmFTS1FsTll2eUpadDlFeTUtY0lJajgzMWU2c2I1emFxdXZVZnBmbTZsVUNsdE5hZ1lPUW9tNUtMaGFTX2t4OWY2MU8xRk51OERkSXpEV1lVWkwwOWVWUk5rZGh6SVY0eEg0M3R3?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE9fcVRYcHk5Y0NIaGRseVJ5amNzM05Jb0JSV3ZLZmRkdEpiVHBWWU1HWDNpZGxZUG5oZFdKdzZLczd5bGpTbXZERUJub3djUmdxZC1SbU5lU0V1TzdvZjc3bnFxdTc0azZQT19KUkJtTGYzSmIwOTN3?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE16OUw0a0toY29KRlJoem5rZ25kQUVRNGllU2lEY05UOWxaNWtiaU9fMDlGbEtuVnZDbzRjZXdhaS1KQ3JHR3hUWGo0YTE4RFVTakpBZ2ZvajRFbkxUQjRKbEs5TmlQa0dTYm5tV2JoZFFTcHZsRzZxOQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T01:05:28+00:00", "published_display": "18 Jun 2026 01:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE1xQktHaXc2V1RvUWJGZTdSMWNsS0Vtalh2YURVXzZDR09BY1YyWlNrb1dwWWpoZjhtbXc4dHRBVno4VkQ0UkNyV09WbGx0b2ttLWZqT2oxMUJpSVdWbTdEUzVMYWtVeGlmZjJmVjln?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T00:54:40+00:00", "published_display": "18 Jun 2026 00:54", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics Ltd (ADXN) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE1iRklOeDNXMGQ5ZFFidWdVbEdWMTNGUHJaYVhnaklYRU5HQ3drUkxkZW5xQVMxWGF5NnVYMXRNLWlGQXV1MjRHN0kxS05YbTJHRjJ3SkdpMjR6a1FOeDZjY0dhWHVRMWlKdEZPZFNqb0o?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T00:19:34+00:00", "published_display": "18 Jun 2026 00:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics (ADXN) Holds Steady \u2013 Consolidation Near Support May Signal Next Move - Short Setup Alerts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOb2NiTWE1RzB3bzN4UGc3VW0wOEU2NVB3cnlZOTZCNnFwX0Y4cDliN0s0bFhqQUpTaHQ5QU8wVFFCaTVOSkhxQ3JFVEk4OWh5NFpPeEk1ZTF1bHE5d2hCYUh2blRUWnF4bzBTMlNMS2FzME82M1JHaXdya18wTmxwUkgwUjZsUjh5YV9GcGtra2ktWEdzM1JrNVdtcFJSZ1VWM29yd3FyOGlXeTU5SVFvMlA3U1pvYlRuMWhZekVydkZodw?oc=5", "source_name": "newsline.com", "published_at": "2026-06-09T16:33:28+00:00", "published_display": "09 Jun 2026 16:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics (NASDAQ: ADXN) details 2026 AGM items and votes", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNNHYxekI0bURYR2tQaEI4NGlRZVNsNmN0bm9QVmI2cU9xaFV0a0RvZU56TF8yYmZyYWlkMF90SUdvQW5SQzNhalBCUDVHNEt2dFNhS2IxWl9XUms5TmJlQjFpMmcwRHBIYjE3clBEdFY4d1dld1A4QU9ka29QNHZQQ0RmTUhvSTFPdnFSeGlHaktFRkwzNlNEQ20wM3drRkJrZ01xaGFIX1NVd2Nqc3YxWFRkbEpiaWFUakE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Convenes Annual General Meeting 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE5sd0xjdVMxTmJJT0dvQ0VQVi1PTUQ3YVlpcmE3RE5sTmV6M3d3Nm9LeTBTTEh6VEFwQXM0bHg3S2FWQUYweElCY3VQbHlIR0RiQVNQbw?oc=5", "source_name": "Taiwan News", "published_at": "2026-06-05T05:00:00+00:00", "published_display": "05 Jun 2026 05:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics (ADXN) Slips 2.49% as Stock Tests Key Support Levels - Sector Leader Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPdUNINXlTYTV1aXd6OW5IZkJpcktFak12akQzaFBQVVF1OS1fRmFDQmo2YS1ING9mNWxwdndwNmFmYWR1cTlBbTdJNExjRUwtZHQ3Qkt5eG1wNTVMTVFldGtNbEcwZDZKTW9BZXRVVkJiYlJpZkZTbWVmSXRaVnpjVVB3ZU03MWlock9NclVvenVKV0kwcV9DUlpaWU54ZVFoZENncThJQ2hhdw?oc=5", "source_name": "newsline.com", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics (ADXN) Regains Rights to ADX71149 After Janss", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPbWlsdGEzUEVfZUlJR2xteER6VEd3cFRZN1k0T2JvNFc4ZTNFNXZPR1J1c2gtVEs4NnlsMFVVcTlMcU5qVWhKa2sySll1Skc5NFlsZTVSREpjUlRzQ3NnV1pJNl90SVdKUW9WSmhobFRjdVQ3NlE2cHA2RnZuR1dkY2RaWnNFb1h6S01TYWpfck10Zi1ReXp4V1JtVXhzN3ZKak1pMXVtOUJhSDlGcDAzdnVuZWY0REZ1anlNYVU0TkFHVUlkakl1dlFRVkN4SldqWTNDdVZqSFdGU1paZmxmdmZn?oc=5", "source_name": "GuruFocus", "published_at": "2025-04-17T07:00:00+00:00", "published_display": "17 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex and Perceptive Launch Neurosterix with $63 Million to", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgJBVV95cUxPcl93eDc1QXptQ2hpWDBOUnRaQzVDN3NGZDlBbEU5RHh5ZEdqcERQZW5qVk5vUnpIUnY2N2xkdVhoTEtkXzRRcWRGUHdKQW10LTd0U3hfRklVdC1mSXVMdGZOMTFINllqNXdGVjBUT05xVG1Ed2tLS3Y1VWZZMWNjTFBXem9JaDh2VkpfQ1RPVk1oQXk0T3ZZTDZtRnNrZDJXQTdmcF9XUDdVUG5jcnZOUjNHN0FfQUdBcW93WmpjZlVMajJ6ZnFkZkZfSjBabDRnSHJMRmdPa3NCWnNmcTJIOW95eUh1YlNjSEZOODVLZlo1VlNRVG9rTXZjNDlwRVg2dDhFZTRJUlJzekw5eDg1LThObVVPSXBqMTR4dFpzUlZ1SWVUeG5RaGgtLWQ5ZDBjQ1JVSVBZTXlyV1hZNVE?oc=5", "source_name": "GlobeNewswire", "published_at": "2024-04-03T07:00:00+00:00", "published_display": "03 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Addex Therapeutics (ADXN) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE13ellTNmhHT2xSS1p6SUVVZVlyM3NxeUlJQzNmOUpvOXVkNi15azNEcndMcVg3RU02NktROWpzSmdDLVM4TDRyellBT3hZYWhpQmJLejJ1Wk8wZw?oc=5", "source_name": "MarketBeat", "published_at": "2020-09-16T02:53:01+00:00", "published_display": "16 Sep 2020 02:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Addex Therapeutics Ltd (SIX:ADXN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9wbG9YbjVZYWp3V0NBYXN5aHBuY3piamVucUxHWVB6MldDU2hQMW5fSmo3WXRnaHN6dWtIOHdla2lBYVhPSXFTaFdBbVlhTlZkbzFfMWhFSTlKUkdvTzNLRUN3WWZLMm8?oc=5", "source_name": "TradingView", "published_at": "2018-02-05T07:37:05+00:00", "published_display": "05 Feb 2018 07:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 63, "total_relevant": 18, "sentiment_summary": {"positive": 2, "negative": 1, "neutral": 15, "score": 49, "total": 18, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 89, "events": [{"event": "general", "label": "Market update", "weight": 8.25, "count": 15}, {"event": "earnings", "label": "Earnings", "weight": 1.65, "count": 3}], "positive_events": 2, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 0.05, "latest_week": "2026-06-19", "one_week_move": 12.2, "four_week_move": -2.5, "twelve_week_move": 15.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.266572, "market_dynamics_buy_signal": false, "relative_strength": -20.896934, "fair_value_gap": -27.8, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 44.2628, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+12.2% over one week, -2.5% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingKey", "count": 9}, {"label": "GlobeNewswire", "count": 2}, {"label": "newsline.com", "count": 2}, {"label": "Stock Titan", "count": 1}, {"label": "Taiwan News", "count": 1}, {"label": "GuruFocus", "count": 1}, {"label": "MarketBeat", "count": 1}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 18}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 15}, {"label": "Earnings", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "89/100 classification confidence."}, {"label": "Company focus", "value": "18", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+12.2% over one week, -2.5% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026"}], "updated_at": "2026-06-22T17:52:14.542715+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}